With the start of a pandemic has dramatically increased the demand for medicines used in complex therapy of patients with COVID-19. We are talking about corticosteroids, the relaxants, analgesics, antibiotics, and drugs for anesthesia and sedation, is required when connecting patients to the ventilator. About it in interview to the edition “Focus” said the Director, business development at JSC “Farmak” Victor Kostyuk.
“Such medicines “Farmak” as propofol, dexamethasone, vasopressin, and many others, has become extremely popular. And although not all of them are registered in the EU, in a situation of abnormal demand (abnormal demand) we got permission to import not only in the UK, Sweden, France, Germany, Poland, but also in Australia, New Zealand, Mexico and Singapore. In addition, we secured a record shipment of complex injectable products in Israel, resulting in the first half of 2020, the country became the second largest export of our products,” – said Kostiuk.
According to his forecast, given the fact that the increase in incidence continues, the drugs used in the treatment of coronavirus, next year will be the main drivers of growth in the export direction “Farmak”.
“Farmak” in April – July exported to the EU countries the drug “Propofol” in excess of $635 thousand, which is used in artificial lung ventilation, including patients with COVID-19, reported the Agency “Interfax-Ukraine”.